SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-022785
Filing Date
2020-08-18
Accepted
2020-08-18 18:58:10
Documents
1
Period of Report
2020-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8062
  Complete submission text file 0000899243-20-022785.txt   9498
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRIDGEBIO PHARMA, INC. 421 KIPLING STREET PALO ALTO CA 94301
Business Address
YAU YI CHING (Reporting) CIK: 0001790097 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 201114891